BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37773852)

  • 21. The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.
    Kaida H; Yasuda T; Shiraishi O; Kato H; Kimura Y; Hanaoka K; Yamada M; Matsukubo Y; Tsurusaki M; Kitajima K; Hattori S; Ishii K
    BMC Cancer; 2022 Nov; 22(1):1176. PubMed ID: 36376801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa.
    Uchinami Y; Myojin M; Takahashi H; Harada K; Shimizu S; Hosokawa M
    Radiat Oncol; 2016 Jun; 11():84. PubMed ID: 27328734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity-modulated radiotherapy with more than 60 Gy improved the survival of inoperable patients with locally advanced esophageal squamous cell carcinoma: A population-based real-world study.
    Zhang W; Xie Q; Zhu B; Wang X; He L; Zhang Y
    Medicine (Baltimore); 2022 Apr; 101(16):e29166. PubMed ID: 35482986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractures of thoracic vertebrae in patients with locally advanced non-small cell lung carcinoma treated with intensity modulated radiotherapy.
    Uyterlinde W; Chen C; Belderbos J; Sonke JJ; Lange C; de Bois J; van den Heuvel M
    Radiother Oncol; 2016 Mar; 118(3):437-41. PubMed ID: 26787423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
    Wang X; Wang Z; Lu WL; Zhao GF
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
    [No Abstract]   [Full Text] [Related]  

  • 26. Vertebral Fractures Following Stereotactic Body Radiotherapy for Spine Oligometastases: A Multi-institutional Analysis of Patient Outcomes.
    Abbouchie H; Chao M; Tacey M; Joon DL; Ho H; Guerrieri M; Ng M; Foroudi F
    Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):433-441. PubMed ID: 32169302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
    Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
    World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary esophageal squamous cell carcinoma after hematopoietic stem cell transplantation.
    Nomura K; Iizuka T; Kaji D; Asano-Mori Y; Ochiai Y; Suzuki Y; Hayasaka J; Yamashita S; Matsui A; Kikuchi D; Taniguchi S; Takazawa Y; Hoteya S
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2137-2144. PubMed ID: 33387042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma.
    Pao TH; Chen YY; Chang WL; Chang JS; Chiang NJ; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
    PLoS One; 2021; 16(5):e0251811. PubMed ID: 33989365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New vertebral fractures after percutaneous vertebroplasty for painful osteoporotic vertebral compression fractures: a clustered analysis and the relevance of intradiskal cement leakage.
    Nieuwenhuijse MJ; Putter H; van Erkel AR; Dijkstra PD
    Radiology; 2013 Mar; 266(3):862-70. PubMed ID: 23204545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatic invasion is a prognostic factor of pathological N0 esophageal squamous cell carcinoma.
    Toriumi T; Yagi K; Ri M; Yajima S; Okumura Y; Aikou S; Yamashita H; Nomura S; Seto Y
    Dis Esophagus; 2022 Jul; 35(7):. PubMed ID: 34937084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
    Wang Q; Qiu Q; Zhang Z; Zhang J; Yang G; Liu C; Li B
    Cancer Med; 2021 Sep; 10(17):5847-5858. PubMed ID: 34363346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does brain radiotherapy improve survival in patients with esophageal squamous cell carcinoma with brain metastasis?
    Lin GS; Luo HC; Fu ZC; Liao SG; Cai LJ; Zhu JF
    Ann Palliat Med; 2020 May; 9(3):637-643. PubMed ID: 32312072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures.
    Yang SC; Chiu YC; Liu PH; Hsieh TJ; Kao YH; Tu YK
    Osteoporos Int; 2019 May; 30(5):1043-1049. PubMed ID: 30706096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of a phase I/II trial of radiation dose escalation by simultaneous integrated boost for locally advanced esophageal squamous cell carcinoma.
    Zhang Y; Feng W; Gao LT; Cai XW; Liu Q; Zhu ZF; Fu XL; Yu W
    Radiother Oncol; 2021 Jun; 159():190-196. PubMed ID: 33812913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
    Wu X; Hu X; Chen J; He L
    Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis.
    Luo HS; Xu HY; Du ZS; Li XY; Wu SX; Huang HC; Lin LX
    Radiat Oncol; 2019 May; 14(1):74. PubMed ID: 31046792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.